Sponsored Content

Symrise has today announced a cash offer to the shareholders of Probi, a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. Symrise is Probi’s largest shareholder and has been a shareholder since 2012. Through its active involvement, Symrise has deep knowledge and understanding of Probi, its operations, and the market it operates in. Symrise has a long-term belief in Probi since the company has a very attractive product offering that makes the health-enhancing benefits of probiotics available to people everywhere, and a fantastic global team. Symrise believes that there is great potential to elevate Probi to the next level under the Symrise group, as a key driver to Symrise’s focused strategy in health.
Probi to realize their investment at an attractive valuation. Symrise has been a long-term sharehold-er in Probi and has acted with a long-term perspective in the best interest of the Company, its teams and shareholders. Today’s offer to Probi’s shareholders reflects Symrise’s conviction that Probi would see its prospects enhanced in a private environment. We are pleased that the offer has re-ceived the full support from Probi’s two other largest shareholders. As a global leader in products supporting health, Symrise is ideally placed to leverage and capitalize on the strong foundation the Probi team has built. By joining forces, we will further strengthen our respective capabilities to serve the market with leading customized solutions, unlocking even greater value for customers globally.”
Further information about the offer including the offer press release that Symrise published today is available at: www.symrise.com/probi.
23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more